£59.99
£59.99
This book is an authoritative introduction to rare cancers in the first year of life. It explores how these malignancies differ biologically and clinically, focusing on their unique genetics, the challenges of early diagnosis, and advances in treatment and family-centered care.
This book offers an accessible yet authoritative introduction to the rare and complex cancers diagnosed within the first year of life. Addressing conditions such as neuroblastoma, leukemia, retinoblastoma, congenital mesoblastic nephroma, and early brain tumors, this concise volume explores how these malignancies differ biologically and clinically from those in older children and adults. With a focus on the unique developmental origins and genetic underpinnings of infantile cancers, the book examines the challenges of early diagnosis, the urgency of effective treatment, and the delicate balance required to protect the rapidly developing infant body. It highlights advances in genomic research, targeted therapies, and survivorship care while underscoring the critical need for family-centered, multidisciplinary approaches. Drawing on current research and clinical practice, this book is an invaluable resource for healthcare professionals, students, and researchers seeking to understand and improve outcomes for the youngest patients facing cancer.
This book uses solution-focused thinking to show how life with cancer may be lived well. Written in a chatty but powerfully effective style, it is for people who have cancer, their families, and friends, as well as the health professionals who seek to help them.
Public fear of breast cancer obscures the facts. Treatments can increase other health risks, while fear itself can impair quality of life. This book explores the history and mystery of breast cancer, from Ancient Egypt to the future, to champion the totality of women’s health.
This book highlights the usefulness of magnetic resonance imaging (MRI) for lung and thoracic tumors. Economical and with no radiation exposure, MRI offers advantages over CT and PET-CT, allowing for qualitative analysis of disease and early assessment of therapeutic effects.
The next generation of oncological hyperthermia selectively heats malignant cells. Due to its selectivity, this innovative concept is safer, less toxic, and uses significantly lower energy. This book shows the challenges, theoretical basis, and clinical results of the method.
As gynaecological cancer survival rates improve, quality of life after treatment is vital. This is the first textbook on managing the physical and psychological effects of treatment. It is essential reading for gynaecological oncology specialists and related disciplines.
This book provides a historical and applicable overview of current Interventional Oncology (IO) approaches. It explores treatment options, medical breakthroughs, and the disease processes themselves. This up-to-date review is crucial for learners and current interventionalists.
Learn how electrical pulses can make cancer treatment more efficient with fewer side effects. Successfully used with chemotherapy on over 3000 patients, this method doesn’t require high-tech resources, making it ideal for less-equipped healthcare settings.
This book describes the latest knowledge on hereditary colorectal cancer syndromes, focusing on management, surveillance, and screening. It discusses multidisciplinary care, risk estimation, genetic information, and future developments in this evolving field.
From a clinical pharmacist specializing in oncology, this book illuminates the fundamental aspects of solid and blood cancers and their novel drug therapies. Emphasizing key concepts, it provides a clear introduction for clinicians and students to understand oncology principles.
This volume covers cancer epidemiology, drug development, and therapies, presenting tools to assess side effects. It also explores patient quality of life, palliative care, and the global disparities that prevent equal access to diagnosis and treatment.
A neurinoma, or schwannoma, is a benign, slow-growing tumor arising from Schwann cells that form the sheath around nerves. It typically displaces, rather than infiltrates, the nerve. Symptoms depend on the tumor’s location. Surgical excision is the treatment of choice.
Obesity is a complex medical disease, not a lifestyle issue. As a global health crisis, it significantly increases the risk of chronic conditions like diabetes and heart disease. It demands evidence-based clinical management, not moral judgment, to address its root causes.
High blood pressure, the “silent killer,” is a leading preventable cause of heart attack, stroke, and kidney disease. This guide offers health professionals a clear path to tackling this silent epidemic through advances in diagnosis, risk management, and patient-centered care.
Processing Your Order
Please wait while we securely process your order.
Do not refresh or leave this page.
You will be redirected shortly to a confirmation page with your order number.
